St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Research
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Influenza virus provides first evidence of bats’ potential as an intermediate host
Explore research showing bats may be an intermediate influenza host.
Blazing a TRAIL in acute myeloid leukemia treatment
See how studies into AML drug reveals new potential target
Study reveals the neurochemical gatekeeper to learning and the key to unlocking it
St. Jude research uncovers neural secrets behind our capacity to learn
Drug which blocks stress granule formation offers insight into biomolecular condensates
See how G3BP inhibitors represent turning point in RNP granule research
Following the breadcrumbs: Gain-of-function mutation leads researchers to new therapeutic target for pediatric AML
Explore the mechanistic insights behind novel pediatric AML therapeutic target
Exploring the interplay between vaccines and immune system development in infants
Explore new research delving into pediatric immune responses to vaccination
CRISPR kickstarts combination drug discovery for neuroblastoma
A CRISPR screen reveals a potential combination therapy for relapsed neuroblastoma.
Finding the big-TIME players holding back CAR T–cell therapy for high-grade gliomas
Explore how tumor-associated macrophages shape CAR T-cell therapy efficacy in high-grade gliomas.
Ribosome production presents a new therapeutic opportunity against Wilms tumor
Discover how disruption ribosomes creation provides promise for “undruggable” cancers.
Just like the real thing: Synthetic gene expression regulators demonstrate success
See how Aseem Ansari's SynGRs target BET proteins, offering potential for treating diseases like Friedreich’s ataxia and advancing BET domain understanding